Clinical Trial: Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (Title in France: Compensation of Vision With the Intelligent Reti
Brief Summary: This study evaluates the safety and effectiveness of the Intelligent Retinal Implants System (IRIS V1)
Detailed Summary:
Sponsor: Pixium Vision SA
Current Primary Outcome: Number of Adverse Events as a Measure of Safety and Tolerability [ Time Frame: Up to 18 month after implantation ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Probable benefit [ Time Frame: Up to 18 months after implantation ]
Original Secondary Outcome: Same as current
Information By: Pixium Vision SA
Dates:
Date Received: May 15, 2013
Date Started: April 2013
Date Completion: November 2019
Last Updated: January 23, 2017
Last Verified: January 2017